Skip to content

Clinical study on Body Lotion in participants having skin dryness

Clinical Evaluation of efficacy and safety of Body Lotion in mild to moderate skin dryness - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094023
Enrollment
30
Registered
2025-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Emami Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed mild to moderate skin dryness assessed using clinical grading score.

Exclusion criteria

Exclusion criteria: 1. Subjects with a known current history of chronic skin diseases or autoimmune diseases, such as atopic dermatitis, psoriasis, chronic urticaria, vitiligo and rosacea 2. Subjects with a tattoo, a scar, moles, too many hairs 3. Subjects with intensive exposure to sunlight or UV-rays within the previous month and foreseen during the study. 4. Subjects who have used facial blemish-lightening products, topical or oral whitening drugs. Moisturizing cream, lotion or oil within 21 days before entering the trial 5. Subjects on any other investigational products within 1 month prior to randomization 6. Subjects with known current tuberculosis, HIV, ischemic heart disease, cancer, kidney failure, liver failure 7. Pregnant and lactating women 8. Known hypersensitivity to any of the ingredients of Emami Body Lotion 9. Other conditions, which in the opinion of the investigators, make patient unsuitable for enrolment or could interfere with his/her participation in, and completion of the study

Design outcomes

Primary

MeasureTime frame
Change in skin cutaneous moisturization or skin drynessTimepoint: Baseline visit (day 0), day 15 and end of study visit (Day 30)

Secondary

MeasureTime frame
1. Change in overall skin texture or roughness (Tactile) and (Visual) 2. Change in overall skin desquamation or flakiness, luminosity or radiance 3. Assessment of skin patch test using Dermal Response Score. 4. Assessment of ability of Body lotion to absorb into the skin and oily or greasy appearance of skin after application of body lotion 5. Assessment of feeling of body lotion on skin 6. Global assessment for overall change 7. Assessment of adverse events, adverse drug reactions including vitals Timepoint: Baseline visit (day 0), day 15 and end of study visit (Day 30)

Countries

India

Contacts

Public ContactDr Sanjay Tamoli

Target Institute of Medical Education and Research Pvt. Ltd

targetinstitute@yahoo.com9322522252

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026